作者 | 刘银平编辑 | 付影 来源 | 独角金融 春节前夕，华宝基金一则人事变动引发市场关注：任职近20年、担任基金经理超13年的指数投资总监胡 洁，一次性卸任在管全部16只产品。这次"清仓式"离任之所以引人注目，不仅因其资历深厚，更在于管 理规模高达1013.62亿元——占据公司指数基金总规模的一半以上，堪称华宝ETF时代的"关键推手"。 作为以ETF产品为主的指数基金经理，胡洁在任期间曾推动公司ETF规模快速扩张。然而，与其规模贡 献形成鲜明对比的是业绩表现：卸任前，她所管产品的近一年整体回报为9.33%，明显跑输同期沪深 300指数逾20%的涨幅。 胡洁的离任，让华宝基金长期以来在权益基金方面的"冰火两重天"结构性困局再次浮出水面。ETF赛道 是华宝的亮点，公司起步较早，近年来在被动产品上持续发力，截至2025年末，非货ETF规模已达 1278.77亿元，同比增长56.38%。正是在ETF的强力拉动下，华宝基金整体管理规模终于在2025年三季 度末突破4000亿元，结束了三年的规模停滞期。 但被动产品的风光背后，主动权益基金则显得格外沉寂。近两年，华宝主动权益基金管理规模多在200 亿元以下徘徊，20 ...

华宝中证沪港深新消费指数A/C成立于2023年04月11日，截至2026年02月13日，其今年来收益率 为-0.14%、-0.17%，成立来收益率为30.40%、29.21%，累计净值为1.3040元、1.2921元。 华宝中证科创创业50ETF联接A/C成立于2021年08月25日，截至2026年02月13日，其今年来收益率 为0.84%、0.79%，成立来收益率为8.50%、7.04%，累计净值为1.0850元、1.0704元。 华宝券商ETF成立于2016年08月30日，截至2026年02月13日，其今年来收益率为-3.28%，成立来收 益率为12.06%，累计净值为1.1206元。 华宝医疗ETF联接A/C成立于2015年05月21日和2021年05月13日，截至2026年02月13日，其今年来 收益率为3.68%、3.66%，成立来收益率为-60.91%、-56.51%，累计净值为0.4702元、0.6083元。 华宝中证医疗ETF成立于2019年05月20日，截至2026年02月13日，其今年来收益率为3.86%，成立 来收益率为5.73%，累计净值为1.0575元。 华宝券商ETF联接A/C成立 ...

资料显示，美年大健康产业控股股份有限公司位于上海市静安区灵石路697号健康智谷9号楼三楼，成立 日期1991年1月22日，上市日期2005年5月18日，公司主营业务涉及健康体检、健康管理业务。主营业务 收入构成为：体检服务95.67%，其他服务4.33%。 华宝中证医疗ETF（512170）基金经理为张放。 截至发稿，张放累计任职时间5年28天，现任基金资产总规模356.41亿元，任职期间最佳基金回报 75.12%， 任职期间最差基金回报-23.7%。 2月24日，美年健康跌5.03%，截至发稿，报6.61元/股，成交5.53亿元，换手率2.08%，总市值258.73亿 元。 从美年健康十大流通股东角度 数据显示，华宝基金旗下1只基金位居美年健康十大流通股东。华宝中证医疗ETF（512170）三季度减 持1512.18万股，持有股数8866.4万股，占流通股的比例为2.29%。根据测算，今日浮亏损失约3103.24万 元。 华宝中证医疗ETF（512170）成立日期2019年5月20日，最新规模252.63亿。今年以来收益3.86%，同类 排名2811/5580；近一年收益5.73%，同类排名3928/429 ...

Content: --------- <doc id='2'>金 融 工 程 研 究 证 券 研 究 报 告 融 资 融 券 周 报</doc> <doc id='9'>1. 市场数据概览 上周（2 月 4 日-2 月 10 日）A 股市场主要指数多数上涨，其中上证 50 涨幅最大， 上涨了 1.74%；创业板指跌幅最大，下跌了 0.13%。此外，上证综指上涨 1.49%， 深证成指上涨 0.59%，科创 50 上涨 0.03%，沪深 300 上涨 1.38%，中证 500 上 涨 0.24%。</doc> <doc id='10'>表 1：A 股市场主要指数上周表现 | 指数名称 | 2 月 3 日收盘价 | 2 月 10 日收盘价 | 周涨跌幅(%) | | --- | --- | --- | --- | | 上证综指 | 4067.74 | 4128.37 | 1.49 | | 深证成指 | 14127.11 | 14210.63 | 0.59 | | 创业板指 | 3324.89 | 3320.54 | -0.13 | | 科创 50 | 1471.07 | 1471.50 | 0.03 | | 沪深 300 | 4660.11 | 4724.30 | 1.38 | | 上证 50 | 3034.58 | 3087.41 | 1.74 | | 中证 500 | 8286.70 | 8306.44 | 0.24 | 资料来源：同花顺，渤海证券研究所 图 1：近一年沪深 300 收盘价与融资买入额占成交额比例</doc> <doc id='12'>资料来源：同花顺，渤海证券研究所 2 月 10 日，沪深两市两融余额为 26,517.83 亿元，较上周减少 459.93 亿元。其 中融资余额为 26,350.49 亿元，较上周减少 460.03 亿元；融券余额为 167.34 亿 元，较上周增加 0.10 亿元。</doc> <doc id='13'>表 2：三市融资融券余额 | 日期 | 沪深京三市余额 | 沪深两市余额 | 沪市余额 | 深市余额 | 京市余额 | 融资余额 | 融券余额 | | --- | --- | --- | --- | --- | --- | --- | --- | | | （亿元） | （亿元） | （亿元） | （亿元） | （亿元） | （亿元） | （亿元） | | 2026-02-04 | 26,928.72 | 26,841.25 | 13,598.65 | 13,242.60 | 87.47 | 26,671.51 | 169.74 | | 2026-02-05 | 26,808.60 | 26,721.87 | 13,547.70 | 13,174.17 | 86.73 | 26,553.94 | 167.93 |</doc> <doc id='15'>| 2026-02-06 | 26,636.60 | 26,549.98 | 13,470.36 | 13,079.62 | 86.62 | 26,383.84 | 166.14 | | --- | --- | --- | --- | --- | --- | --- | --- | | 2026-02-09 | 26,644.00 | 26,556.13 | 13,475.12 | 13,081.01 | 87.87 | 26,387.82 | 168.31 | | 2026-02-10 | 26,604.75 | 26,517.83 | 13,459.14 | 13,058.69 | 86.92 | 26,350.49 | 167.34 | 资料来源：同花顺，渤海证券研究所 图 2：近期融资业务情况（亿元） 图 3：近期融券业务情况（亿元）</doc> <doc id='24'>2 月 10 日，融资融券个人投资者数量为 798.23 万名，较上周增长 0.24%；融资 融券机构投资者数量为 51,114 家，较上周增长 0.11%。有融资融券负债的投资者 数量为 1,901,935 名，较上周下降 0.97%。户均融资融券余额为 1,398,825 元， 较上周减少 10,417 元。有融资融券负债的投资者数量占全体融资融券投资者数 量的占比为 23.68%，较上周减少 0.29 个百分点。2 月 4 日-2 月 10 日每日平均 参与融资融券交易的投资者数量为 432,017 名，较前一周下降 17.79%。</doc> <doc id='28'>2. 行业融资融券特征 从申万一级行业来看，煤炭、综合和轻工制造等行业涨幅较大，有色金属、通信 和国防军工等行业跌幅较大。</doc> <doc id='29'>资料来源：同花顺，渤海证券研究所 融资方面，传媒、综合和环保行业融资净买入额较多，有色金属、通信和非银金 融行业融资净买入额较少。</doc> <doc id='32'>资料来源：同花顺，渤海证券研究所 融券方面，上周传媒、煤炭和机械设备行业融券净卖出额较多，有色金属、食品 饮料和国防军工行业融券净卖出额较少。</doc> <doc id='35'>上周融资买入额占成交额比例较高的行业为非银金融、通信和电子，较低的行业 为纺织服饰、轻工制造和建筑材料；融资余额占流通市值比例较高的行业为计算 机、通信和国防军工，较低的行业为石油石化、银行和煤炭。</doc> <doc id='37'>行业名称 融资买入额占成交额(%) 较上周变化(pct.) 融资余额占流通市值(%) 较上周变化(pct.) 非银金融 11.13 0.10 3.04 -0.11 通信 10.57 -0.46 3.42 -0.13 电子 9.17 -0.14 3.13 -0.03 国防军工 8.73 -0.02 3.28 -0.03 计算机 8.63 -0.05 4.09 -0.02 电力设备 8.50 0.06 2.95 -0.07 有色金属 8.40 -1.14 2.76 -0.05 钢铁 8.13 -0.47 1.71 -0.08 银行 7.94 -1.01 0.82 -0.05 传媒 7.89 0.14 3.07 -0.04 煤炭 7.78 -0.79 0.88 -0.10 公用事业 7.74 -0.30 1.73 -0.02 美容护理 7.72 1.11 2.56 -0.12 汽车 7.72 0.01 2.97 -0.08 家用电器 7.67 0.32 2.01 -0.12 医药生物 7.61 -0.37 2.74 -0.11 机械设备 7.38 0.03 2.51 -0.07 建筑装饰 7.35 -0.83 2.37 -0.03 房地产 7.27 -0.45 3.05 -0.17 基础化工 7.25 -0.36 2.31 -0.09 综合 7.17 0.20 2.84 -0.14 农林牧渔 6.84 -0.46 2.73 -0.08 表 3：上周标的券所属行业融资情况</doc> <doc id='39'>| 交通运输 | 6.64 | -1.07 | 1.38 | -0.09 | | --- | --- | --- | --- | --- | | 食品饮料 | 6.62 | -0.13 | 1.16 | -0.05 | | 石油石化 | 6.40 | -0.70 | 0.66 | -0.03 | | 环保 | 6.32 |

Group 1 - The stock ETF market experienced a significant net outflow of 790 billion yuan in January, with broad-based ETFs being the main contributors to this outflow [2] - On February 2, the first trading day of the month, stock ETFs saw a net outflow of 13.771 billion yuan, influenced by a sharp decline in the three major stock indices [2] - Broad-based ETFs and the metals sector were the largest "bloodletting" categories, while sector-specific ETFs like semiconductors and pharmaceuticals attracted significant inflows [2][3] Group 2 - As of February 2, the total scale of 1,321 stock ETFs (including cross-border ETFs) was 4.09 trillion yuan, showing a notable decrease due to the market downturn [3] - Sector-specific ETFs and Hong Kong stock ETFs saw substantial inflows, with 3.715 billion yuan and 3.346 billion yuan respectively on the previous trading day [3] - The semiconductor sector had a remarkable net inflow of 2.61 billion yuan on February 2, with the Guolian An CSI All-Share Semiconductor ETF leading with a net inflow of 903 million yuan [3] Group 3 - Over the past five days, the SGE Gold 9999 index saw inflows exceeding 13.9 billion yuan, while the specialized chemical index attracted over 7 billion yuan [4] - Leading institutions like E Fund reported a total ETF scale of 642.71 billion yuan, with a net inflow of 800 million yuan on the previous day [4] - Notable single product inflows included 526 million yuan for the ChiNext ETF and 352 million yuan for the Hang Seng Technology ETF [4] Group 4 - Broad-based ETFs continued to experience significant outflows, with a net outflow of 23.778 billion yuan on the previous day, leading to a scale decrease of 68.672 billion yuan [5] - The CSI 500 ETF had the largest single-day outflow of 13.02 billion yuan, followed by the CSI 300 ETF with 7.2 billion yuan [5] Group 5 - The metals sector also faced notable outflows, with a net outflow of 4.39 billion yuan, influenced by expectations surrounding the Federal Reserve's monetary policy and profit-taking sentiments [6] - Despite short-term volatility, the long-term investment logic for the metals sector remains solid, supported by global manufacturing cycles and energy transition demands [6] Group 6 - Current market adjustments are viewed as providing better valuation windows for long-term investments, with a stable long-term market outlook supported by policy measures and improving economic fundamentals [7] - Key factors include ongoing policy support, marginal improvements in economic indicators, and a favorable funding environment with increasing allocations to A-shares from various institutional investors [7]

Group 1 - The core point of the news is that Zhaoyan New Drug's stock price dropped by 5.05% to 36.09 CNY per share, with a trading volume of 569 million CNY and a turnover rate of 2.45%, resulting in a total market capitalization of 27.044 billion CNY [1] - Zhaoyan New Drug Research Center Co., Ltd. specializes in non-clinical safety evaluation services for drugs, with its main business revenue composition being 95.59% from non-clinical research services, 4.34% from clinical services, and 0.07% from experimental model supply [1] - The company was established on February 25, 1998, and was listed on August 25, 2017, located in Beijing Economic and Technological Development Zone [1] Group 2 - Among the top ten circulating shareholders of Zhaoyan New Drug, Huabao Fund's Huabao CSI Medical ETF (512170) reduced its holdings by 2.1693 million shares in the third quarter, now holding 12.4838 million shares, which accounts for 1.67% of the circulating shares [2] - The estimated floating loss for Huabao CSI Medical ETF today is approximately 23.9689 million CNY [2] - The fund was established on May 20, 2019, with a current scale of 25.263 billion CNY, and has achieved a year-to-date return of 4.77% and a one-year return of 14.49% [2]

Group 1 - The total margin balance of ETFs in the Shanghai and Shenzhen markets as of January 30 is 120.251 billion yuan, a decrease of 2.896 billion yuan from the previous trading day [1] - The financing balance of ETFs is 112.88 billion yuan, down by 2.767 billion yuan, while the margin balance for securities lending is 7.371 billion yuan, a decrease of 0.129 billion yuan [1] - On January 30, 241 ETFs experienced net financing inflows, with the E Fund CSI Hong Kong Securities Investment Theme ETF leading with a net inflow of 84.1736 million yuan [1] Group 2 - Other ETFs with significant net financing inflows include the Huaxia Hang Seng Internet Technology ETF, the FTSE China A50 ETF, the Huabao CSI Medical ETF, the Bosera Gold ETF, and the Huaan Gold ETF [1]

Group 1 - The core viewpoint of the news is the performance and financial details of Sanbo Brain Science Hospital Management Group Co., Ltd, which saw a stock price increase of 5.12% to 80.28 CNY per share, with a trading volume of 601 million CNY and a market capitalization of 16.537 billion CNY [1] - The company, established on November 25, 2003, and listed on May 5, 2023, primarily provides medical services, with revenue composition as follows: 74.35% from medical services, 25.02% from pharmaceuticals, 0.39% from other sources, and 0.24% from supply chain [1] Group 2 - From the perspective of the top ten circulating shareholders, Huabao Fund's Huabao CSI Medical ETF (512170) reduced its holdings by 749,300 shares in the third quarter, now holding 4.0556 million shares, which accounts for 2.52% of the circulating shares [2] - The estimated floating profit from this reduction is approximately 15.8575 million CNY [2] - The Huabao CSI Medical ETF was established on May 20, 2019, with a current scale of 25.263 billion CNY, yielding 4.83% this year, ranking 3398 out of 5551 in its category, and 14.55% over the past year, ranking 3650 out of 4285 [2] Group 3 - The fund manager of Huabao CSI Medical ETF is Hu Jie, who has a cumulative tenure of 13 years and 109 days, managing total assets of 101.358 billion CNY [3] - During Hu Jie's tenure, the best fund return was 161.34%, while the worst was -98.01% [3]

Group 1 - The core viewpoint of the news is that Aide Biological has seen a significant increase in its stock price, rising 5.23% to 22.95 CNY per share, with a total market capitalization of 8.986 billion CNY and a trading volume of 1.79 billion CNY [1] - Aide Biological specializes in the research, production, and sales of molecular diagnostic products for precision oncology, with its main revenue sources being testing reagents (83.43%), clinical research services (9.84%), and testing services (5.61%) [1] - The company has experienced a cumulative stock price increase of 4.06% over the past three days, indicating positive market sentiment [1] Group 2 - Among the top shareholders of Aide Biological, Huabao Fund's Huabao Zhongzheng Medical ETF (512170) reduced its holdings by 1.3344 million shares in the third quarter, now holding 7.7022 million shares, which is 1.98% of the circulating shares [2] - The Huabao Zhongzheng Medical ETF has achieved a year-to-date return of 12.08% and a one-year return of 25.54%, ranking 675 out of 5,517 and 3,238 out of 4,203 respectively in its category [2] - The fund manager, Hu Jie, has a tenure of 13 years and has managed a total asset size of 100.204 billion CNY, with the best fund return during his tenure being 173.62% [3]

数据显示，华宝基金旗下1只基金位居美年健康十大流通股东。华宝中证医疗ETF（512170）三季度减 持1512.18万股，持有股数8866.4万股，占流通股的比例为2.29%。根据测算，今日浮盈赚取约5408.5万 元。 华宝中证医疗ETF（512170）成立日期2019年5月20日，最新规模264.04亿。今年以来收益10.11%，同 类排名457/5579；近一年收益21.65%，同类排名3340/4202；成立以来收益12.09%。 1月12日，美年健康涨9.95%，截至发稿，报6.74元/股，成交1.34亿元，换手率0.51%，总市值263.82亿 元。 资料显示，美年大健康产业控股股份有限公司位于上海市静安区灵石路697号健康智谷9号楼三楼，成立 日期1991年1月22日，上市日期2005年5月18日，公司主营业务涉及健康体检、健康管理业务。主营业务 收入构成为：体检服务95.67%，其他服务4.33%。 从美年健康十大流通股东角度 责任编辑：小浪快报 截至发稿，胡洁累计任职时间13年92天，现任基金资产总规模1002.04亿元，任职期间最佳基金回报 173.62%， 任职期间最差基金回报-98.0 ...